Compare TG Therapeutics Inc (TGTX) vs Workday Inc (WDAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TG Therapeutics Inc vs Workday Inc — how do they compare? TG Therapeutics Inc trades at $54.06 (market cap $8.26B), while Workday Inc trades at $140.65 (market cap $36.36B). The key difference: Workday Inc is far larger — about 4.4× TG Therapeutics Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals.
| TGTX | WDAY | |
|---|---|---|
Market Cap | $8.26B | $36.36B |
Sector | Health | Technology |
52-Week High | $59.06 | $247.69 |
52-Week Low | $26.39 | $112.55 |
Enterprise Value | $8.50B | $35.81B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TG Therapeutics Inc
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →About Workday Inc
Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.
Read more on WDAY →
